Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Professor Moeen gives a detailed explanation on how Olipudase Alfa acts in the body once administered.

Consensus Guidelines for the Clinical Management of ASMD

Consensus Guidelines for the Clinical Management of ASMD

Impact of symptoms and risk of ASMD on patients and caregivers

Impact of symptoms and risk of ASMD on patients and caregivers

Differential diagnostics for ASMD in patients suspected to have GD

Differential diagnostics for ASMD in patients suspected to have GD

Inside Diabetes: ATTD Edition | Type 1 Diabetes

Inside Diabetes: ATTD Edition | Type 1 Diabetes

BIOCHEMICAL DIAGNOSTIC STRATEGY IN FEMALES SUSPECTED OF FABRY DISEASE

BIOCHEMICAL DIAGNOSTIC STRATEGY IN FEMALES SUSPECTED OF FABRY DISEASE

ROLE OF ECG IN DIFFERENTIAL DIAGNOSIS OF ANDERSON–FABRY DISEASE WITH HCM

ROLE OF ECG IN DIFFERENTIAL DIAGNOSIS OF ANDERSON–FABRY DISEASE WITH HCM

DIAGNOSING FABRY DISEASE IN CLINICAL PRACTICE

DIAGNOSING FABRY DISEASE IN CLINICAL PRACTICE

Management of ASMD - Expert opinion: Professor Fatma Al- Jasmi

Management of ASMD - Expert opinion: Professor Fatma Al- Jasmi

Professor Fatma explains the effect of Olipudase Alfa on the symptoms presented in patients with ASMD.

Management of ASMD - Expert opinion: Professor Tawfeq Ben Omran

Management of ASMD - Expert opinion: Professor Tawfeq Ben Omran

Professor Tawfeq explains the benefits of the ERT Olipudase Alfa on patients diagnosed with ASMD.

Pompe Care Podcast Series

Pompe Care Podcast Series

Welcome to Pompe Care podcast series, today’s episodes we speak to Dr. Amal Al Teneiji, Metabolic Genetics Consultant at Sheikh Khalifa Medical City Abu Dhabi, about Pompe disease. We talk about typical diagnosis of patient journey, challenges facing, new diagnostic technologies, effective ways to support patients and families and social stigma.

Hear From An Expert On Identify Patients Who Are Appropriate Candidates For Biologic Treatment

Hear From An Expert On Identify Patients Who Are Appropriate Candidates For Biologic Treatment

On average the typical patients with nasal polyps have had +1 sinus surgery, sinus surgery dose not cure the nasal polyps. A medication where i can prevent revision sinus surgery...a good thing for me and for the patient.